Apiject Holdings Inc. has signed a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North Carolina, which will house two advanced Blow-Fill-Seal (BFS) production lines and operate as an FDA-registered 503B outsourcing facility focused on producing essential generic injectable medicines currently on the FDA’s drug shortage list. The site will also serve as the corporate headquarters of Vanguard Utility, Apiject’s operational subsidiary. This investment ...